Welcome to our dedicated page for AMERICAN HEALTHCARE REIT news (Ticker: AHR), a resource for investors and traders seeking the latest updates and insights on AMERICAN HEALTHCARE REIT stock.
American Healthcare REIT, Inc. (NYSE: AHR) is a healthcare-focused real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate. The company reports that it focuses primarily on senior housing communities, skilled nursing facilities and outpatient medical buildings across the United States, as well as properties in the United Kingdom and the Isle of Man. This news page aggregates company announcements, earnings updates and other public disclosures related to AHR’s operations and capital markets activity.
Investors following AHR news can find information on quarterly earnings releases, guidance updates and Same-Store Net Operating Income (NOI) performance across its segments, including integrated senior health campuses (ISHC), outpatient medical, triple-net leased properties and senior housing operating properties (SHOP). The company regularly announces acquisition activity within its operating portfolio, development and expansion projects, lease buyouts and dispositions of non-core properties, providing insight into how it manages and grows its healthcare real estate holdings.
American Healthcare REIT also issues press releases regarding capital markets transactions, such as public offerings of common stock on a forward basis and at-the-market equity offering programs, along with details about the use of proceeds. In addition, the company’s news flow includes board-authorized quarterly cash distributions, corporate responsibility initiatives and participation in investor conferences. Readers can use this page to monitor the latest official communications from American Healthcare REIT, Inc. and to review how the company describes trends in its portfolio, operating segments and financing activities over time.
American Healthcare REIT (NYSE: AHR) has priced an upsized public offering of 17,400,000 shares of common stock at $23.55 per share. The company has granted underwriters a 30-day option to purchase up to an additional 2,610,000 shares. Net proceeds will be used to acquire the remaining 24% minority interest in Trilogy Holdings, and to repay debt on existing credit lines. The offering is expected to close on September 20, 2024. BofA Securities, Morgan Stanley, and KeyBanc Capital Markets are acting as joint book-running managers, with several other firms in supporting roles. The offering is being made pursuant to the company's effective shelf registration statement filed with the SEC.
American Healthcare REIT (NYSE: AHR) has announced a primary public offering of 14,500,000 shares of its common stock. The company plans to grant underwriters a 30-day option to purchase up to an additional 2,175,000 shares. Proceeds will be used to acquire its joint venture partner's 24% minority stake in Trilogy Holdings, and to repay debt on existing lines of credit. BofA Securities, Morgan Stanley, and KeyBanc Capital Markets are acting as joint book-running managers for the offering. The stock issuance is being made under the company's effective shelf registration statement filed with the SEC. A preliminary prospectus supplement and accompanying prospectus will be available from the underwriters or the SEC's EDGAR database.
American Healthcare REIT (NYSE: AHR) has announced a quarterly distribution of $0.25 per share for the third quarter of 2024. This distribution will be paid in cash on October 18, 2024 to shareholders of record as of September 20, 2024. The announcement demonstrates the company's commitment to providing regular returns to its investors, which is typical for Real Estate Investment Trusts (REITs). This distribution maintains consistency with previous quarters, suggesting stability in the company's cash flow and dividend policy.
American Healthcare REIT (NYSE: AHR) has announced its participation in the BofA Securities 2024 Global Real Estate Conference. Key executives, including CFO Brian Peay, COO Gabe Willhite, CIO Stefan Oh, and VP of Investor Relations & Finance Alan Peterson, will take part in a roundtable presentation on Thursday, September 12, 2024, from 10:20 a.m. to 10:55 a.m. Eastern Time.
The presentation will be broadcast live via webcast, with a replay available for up to one year following the conference. This event provides an opportunity for investors and analysts to gain insights into AHR's strategies and performance in the healthcare real estate sector.
Shepherd Smith Edwards and Kantas is offering free consultations to American Healthcare REIT (NYSE:AHR) investors following a 3% share price drop on August 6, 2024. AHR, formed from the merger of Griffin-American Healthcare REIT III, IV, and American Healthcare Investors, debuted on the NYSE in February 2024 with a 56 million share IPO at $12/share. Legacy investors, however, had purchased 66 million shares at $40/share.
The REIT's portfolio, valued at $4.6B in September 2023, includes medical office buildings, skilled nursing facilities, and hospitals. Concerns have arisen about potential broker misconduct in recommending AHR, given its high commissions and fees. Investors may explore legal options for recovery, as the firm has previously helped recoup millions for clients affected by negligent stockbrokers.
American Healthcare REIT (NYSE: AHR) reported strong Q2 2024 results and increased its full-year 2024 guidance. Key highlights include:
- GAAP net income of $2.9 million, up from a $11.9 million loss in Q2 2023
- Normalized FFO of $0.33 per diluted share
- Total portfolio Same-Store NOI growth of 15.7%, driven by strong performance in SHOP (49.1%) and ISHC (24.1%) segments
- Increased full-year 2024 Same-Store NOI growth guidance to 12-14% from 5-7%
- Raised NFFO guidance to $1.23-$1.27 per share from $1.18-$1.24
- Improved Net-Debt-to-Adjusted EBITDA from 6.4x to 5.9x
Management cited strong demand for healthcare real estate and expects elevated Same-Store NOI growth to continue due to the demand-supply imbalance in long-term care.
American Healthcare REIT (NYSE: AHR) announced it will release its second quarter 2024 earnings on August 5, 2024, after market close. The company will hold a public conference call and webcast on August 6, 2024, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time, where executives will review the Q2 2024 results, discuss recent events, and conduct a Q&A session. The webcast can be accessed via a provided link, and a digital replay will be available on the company's Investor Relations website shortly after the call. The full earnings report and supplemental data will be posted on the Investor Relations section on August 5, 2024.
American Healthcare REIT (NYSE: AHR) has declared a quarterly distribution of $0.25 per share for Q2 2024.
The cash distribution will be payable on or about July 19, 2024, to shareholders of record as of June 27, 2024.
This includes holders of common stock, Class T common stock, and Class I common stock.
American Healthcare REIT (NYSE: AHR) announced that its senior management team, including CEO and President Danny Prosky, CFO Brian S. Peay, and COO Gabe M. Willhite, will present at Nareit's REITweek: 2024 Investor Conference. The presentation is scheduled for June 4, 2024, from 11:00 a.m. to 11:30 a.m. Eastern Time. A live webcast and a 30-day replay will be available for those who cannot attend the conference in person.
American Healthcare REIT (NYSE: AHR) announced its Q1 2024 results, reporting a GAAP net loss of $(0.04) per share but a Normalized Funds from Operations (NFFO) of $0.30 per share. The company achieved a 7.1% increase in total portfolio Same-Store (SS) revenue, with a 13.0% growth in SS Net Operating Income (NOI). Significant NOI growth was seen in senior housing operating properties (33.5%) and integrated senior health campuses (19.9%).
The company disposed of $15.6 million in Non-Core Properties and acquired a 14-property portfolio in Oregon for $94.5 million. AHR also completed a public offering of 64.4 million shares at $12.00 per share, raising substantial capital to pay down $721.5 million in debt. The company has maintained its full-year 2024 guidance, projecting NFFO per share between $1.18 and $1.24.